Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,147 | 4 | 94.1% |
| Travel and Lodging | $449.97 | 3 | 3.5% |
| Food and Beverage | $306.14 | 3 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12,663 | 8 | $0 (2021) |
| GUERBET LLC | $150.00 | 1 | $0 (2022) |
| Tempus AI, Inc | $90.30 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90.30 | 1 | Tempus AI, Inc ($90.30) |
| 2022 | $150.00 | 1 | GUERBET LLC ($150.00) |
| 2021 | $100.84 | 1 | Novartis Pharmaceuticals Corporation ($100.84) |
| 2020 | $9,347 | 2 | Novartis Pharmaceuticals Corporation ($9,347) |
| 2018 | $3,215 | 5 | Novartis Pharmaceuticals Corporation ($3,215) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $90.30 | General |
| 06/06/2022 | GUERBET LLC | LIPIODOL (Drug) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: ETHIODIZED OIL | ||||||
| 08/17/2021 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $100.84 | General |
| 11/10/2020 | Novartis Pharmaceuticals Corporation | BYL719 (Drug) | Consulting Fee | Cash or cash equivalent | $4,673.50 | General |
| 11/09/2020 | Novartis Pharmaceuticals Corporation | BYL719 (Drug) | Consulting Fee | Cash or cash equivalent | $4,673.50 | General |
| 03/17/2018 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,650.00 | General |
| 03/17/2018 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $204.86 | General |
| 03/17/2018 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $199.11 | General |
| 03/17/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $115.00 | General |
| 03/17/2018 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $46.00 | General |
About Dr. Ahmad Alomari, M.D
Dr. Ahmad Alomari, M.D is a Diagnostic Radiology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497861355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ahmad Alomari, M.D has received a total of $12,903 in payments from pharmaceutical and medical device companies, with $90.30 received in 2024. These payments were reported across 10 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($12,147).
Practice Information
- Specialty Diagnostic Radiology
- Location Boston, MA
- Active Since 08/22/2006
- Last Updated 01/15/2013
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1497861355
Products in Payments
- BYL719 (Drug) $9,347
- LIPIODOL (Drug) $150.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Boston
Andrew Kompel, M.d, M.D
Diagnostic Radiology — Payments: $3.4M
Gregg Miller, M.d, M.D
Diagnostic Radiology — Payments: $3.0M
Stephan Anderson, M.d, M.D
Diagnostic Radiology — Payments: $2.4M
Ashraf Thabet, M.d, M.D
Diagnostic Radiology — Payments: $1.7M
Dr. Mukesh Harisinghani, Md, MD
Diagnostic Radiology — Payments: $1.4M
Subba Digumarthy, Md, MD
Diagnostic Radiology — Payments: $1.1M